Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Letrozole 6 Tamoxifen 4 Cisplatin 4 Anastrozole 4 ribociclib 3 exemestane 3 Vancomycin 3 Specimen Handling 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Human Papillomavirus Recombinant Vaccine nonavalent 3 Dexamethasone 3 Carboplatin 3 Bevacizumab 3 trametinib 2 toripalimab 2 encorafenib 2 dabrafenib 2 binimetinib 2 atezolizumab 2 asciminib 2 Vincristine 2 Sodium Chloride 2 Rituximab 2 Prednisone 2 Papillomavirus Vaccines 2 Methotrexate 2 Medroxyprogesterone Acetate 2 Lenalidomide 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Quality of Life × 90 days × Clear all

NCT06646471 2026-04-29

PROMETHEE

Groupe Francais De Pneumo-Cancerologie

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡